Pablo Sanchis, Associate Member Council at American Association for Cancer Research, shared on LinkedIn:
“Honored to share my work on baseline immune programs and BCG resistance in non-muscle-invasive bladder cancer (NMIBC) at ESMO2026 in Madrid!
As a non-physician researcher, attending ESMO – European Society for Medical Oncology for the first time is being a valuable opportunity to exchange perspectives with healthcare professionals and industry representatives, and to explore how translational research can better address clinical needs.
Many thanks to the entire team behind this work and to International Cancer Foundation (ICF) for supporting this presentation!”
You can also read:
